Skip to main content
Joshua Bauml, MD, Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

JoshuaMichaelBaumlMD

Oncology Philadelphia, PA

Hematology/Oncology

Dr. Bauml is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bauml's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology/Oncology, 2011 - 2014
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineResidency, Internal Medicine, 2008 - 2011
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineClass of 2008

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2022
  • NY State Medical License
    NY State Medical License 2009 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus–Associated Oropharyngeal Carcinoma in Older Patients  
    Harman S Parhar, Karthik Rajasekaran, Ara A Chalian, Christopher H Rassekh, Roger B Cohen, Joshua Bauml, Gregory S Weinstein, Robert M Brody, JAMA Otolaryngology–Head & Neck Surgery
  • Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data  
    Ravi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
  • Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer  
    Gregory S Weinstein, Charu Aggarwal, Roger B Cohen, Joshua Bauml, Alexander Lin, Clinical Cancer Research
  • Join now to see all

Lectures

  • Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran's health ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • At the Forefront of Discovery: From Early Detection to New Treatments for Lung Cancer
    At the Forefront of Discovery: From Early Detection to New Treatments for Lung CancerNovember 1st, 2019
  • The Benefit of Using Immunotherapy with Ablation in NSCLC
    The Benefit of Using Immunotherapy with Ablation in NSCLCOctober 10th, 2019
  • Added Immunotherapy Post-Ablative Therapy for Metastatic Lung Cancer
    Added Immunotherapy Post-Ablative Therapy for Metastatic Lung CancerAugust 29th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations